+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies



ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies



Nephrology, Dialysis, Transplantation 24(1): 298-303



ABO incompatible kidney transplantation using antigen-specific immunoadsorption is increasingly performed but data on outcome, complications and protocol biopsies are still scarce. The present prospective single-centre study was aimed at these issues. This was a prospective single-centre cohort study of 10 successive ABO incompatible living donor kidney transplantations at the University Hospital Basel from September 2005 to October 2007. The following parameters were closely monitored during the whole follow-up: graft function, albuminuria, blood group antibody titres, CD19+ cell count, total IgG and IgG subclasses, CMV antigenaemia, decoy cells in the urine, EBV and polyoma BK virus PCR in the blood. Protocol biopsies were performed on Days 0 and 7 after 3, 6, 12 and 18 months. Patient and graft survival is 100% after a median follow-up of 489 days (range 183-916 days). Median serum creatinine is 137 micromol/l (range 70-215 micromol/l), and median urine albumin-creatinine ratio (UACR) is 3.1 mg/ mmol (range 0.6-7.8 mg/mmol) at the time of the last follow-up. All patients had sustained diminished CD19+ cell count and/or total IgG concentrations. Neither CMV antigenaemia nor EBV replication in the blood was observed. Seven patients had positive polyoma BK virus replication in the blood but none developed polyoma virus-associated nephropathy (PVAN). Protocol biopsies revealed rejection Banff IIa in three patients on Day 7, and in one patient after 3 and 6 months. Banff Ia rejection was found in five patients. All rejection episodes resolved. Mild signs of chronic antibody-mediated rejection were observed in five patients. ABO-incompatible kidney transplantation seems to be successful and safe. Modifications of the current protocol may be possible and may further reduce potential side effects and costs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051289815

Download citation: RISBibTeXText

PMID: 18728155

DOI: 10.1093/ndt/gfn478


Related references

New strategies in living donor kidney transplantation – blood group incompatible and crossover transplantation. Therapeutische Umschau. Revue Therapeutique 72(8): 525-527, 2015

Histologic outcomes in ABO blood group incompatible living donor kidney transplantation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 181A, 2002

Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation. International Journal of Urology 22(10): 931-936, 2016

Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. American Journal of Transplantation 6(8): 1841-1847, 2006

Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. American Journal of Transplantation 4(1): 101-107, 2003

Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. Transplantation Proceedings 48(4): 1134-1138, 2017

Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation. Clinical Transplantation 24 Suppl 22: 16-21, 2010

Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation 89(6): 702-706, 2010

Comparative analysis of ABO-incompatible living donor kidney transplantation with ABO-compatible grafts: a single-center experience in Korea. Transplantation Proceedings 45(8): 2931-2936, 2014

Right Hepatic Lobe And Kidney Transplantation From The Same Living Donor: 5 Cases Including 1 Abo-Incompatible. Transplantation 86(Suppl.): 95-96, 2008

Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. American Journal of Transplantation 8(1): 86-94, 2007

Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Yearbook of Urology 2009: 37-38, 2009

Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 75(8): 1204-1213, 2003

Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies. Transplantation 101(6): 1416-1422, 2016

Analysis of caudate lobe biliary anatomy and its implications in living donor liver transplantation - a single centre prospective study. Transplant International 2018, 2018